Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
58.65
-0.07 (-0.12%)
Jul 31, 2025, 1:44 PM CST
SHA:603392 Revenue
Beijing Wantai Biological Pharmacy Enterprise had revenue of 400.63M CNY in the quarter ending March 31, 2025, a decrease of -46.76%. This brings the company's revenue in the last twelve months to 1.89B, down -43.92% year-over-year. In the year 2024, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 2.25B, down -59.25%.
Revenue (ttm)
1.89B
Revenue Growth
-43.92%
P/S Ratio
39.23
Revenue / Employee
499.61K
Employees
3,790
Market Cap
74.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.25B | -3.27B | -59.25% |
Dec 31, 2023 | 5.51B | -5.67B | -50.73% |
Dec 31, 2022 | 11.19B | 5.43B | 94.51% |
Dec 31, 2021 | 5.75B | 3.40B | 144.25% |
Dec 31, 2020 | 2.35B | 1.17B | 98.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.48B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |